Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Lipid Res ; 65(3): 100509, 2024 03.
Article in English | MEDLINE | ID: mdl-38295984

ABSTRACT

Alcohol binge drinking allows the translocation of bacterial lipopolysaccharide (LPS) from the gut to the blood, which activates the peripheral immune system with consequences in neuroinflammation. A possible access/direct signaling of LPS to/in the brain has not yet been described under alcohol abuse conditions. Apolipoproteins are compounds altered by alcohol with high affinity to LPS which may be involved in its transport to the brain or in its elimination. Here, we explored the expression of small components of LPS, in its free form or bound to apolipoproteins, in the brain of female and male rats exposed to alcohol binges. Animals received ethanol oral gavages (3 g/kg every 8 h) for 4 days. LPS or its components (Lipid A and core), LPS-binding protein, corticosterone, lipoproteins (HDL, LDL), apolipoproteins (ApoAI, ApoB, and ApoE), and their receptors were measured in plasma and/or in nonperfused prefrontal cortex (PFC) and cerebellum. Brain LipidA-apolipoprotein aggregates were determined by Western blotting and confirmed by co-immunoprecipitation. In animals exposed to alcohol binges: 1) plasma LPS-binding protein was elevated in both sexes; 2) females showed elevations in plasma ApoAI and corticosterone levels; 3) Lipid A formed aggregates with ApoAI in the female PFC and with ApoB in males, the latter showing Toll-like receptor 4 upregulation in PFC but not females. These results suggest that small bacterial components are present within the brain, forming aggregates with different apolipoproteins, depending on the sex, after alcohol binge intoxications. Results may have implications for the crosstalk between alcohol, LPS, and neuroinflammation.


Subject(s)
Ethanol , Lipopolysaccharides , Rats , Male , Female , Animals , Lipopolysaccharides/pharmacology , Lipopolysaccharides/metabolism , Neuroinflammatory Diseases , Lipid A/metabolism , Corticosterone/metabolism , Apolipoproteins/metabolism , Apolipoproteins E/metabolism , Brain/metabolism , Apolipoproteins B/metabolism
2.
Br J Pharmacol ; 175(24): 4464-4479, 2018 12.
Article in English | MEDLINE | ID: mdl-30248186

ABSTRACT

BACKGROUND AND PURPOSE: Chronic alcohol consumption alters the gut-brain axis, but little is known about alcohol binge episodes on the functioning of the intestinal barrier. We investigated the influence of ethanol binges on bacterial translocation, gut inflammation and immunity, and tight junction (TJ) structure and the ability of the biolipid oleoylethanolamide (OEA) to prevent ethanol binge-induced intestinal barrier dysfunction. EXPERIMENTAL APPROACH: OEA was injected i.p. before repeated ethanol administration by oral gavage. Plasma, spleen, liver and mesenteric lymph nodes (MLN) were collected in sterile conditions for determination of bacterial load. Immune/inflammatory parameters, TJ proteins and apoptotic markers were determined in colonic tissue by RT-PCR and Western blotting. TJ ultrastructure was examined by transmission electron microscopy. KEY RESULTS: Ethanol binges induced bacterial translocation to the MLN (mainly) and spleen. Colonic tissues showed signs of inflammation, and activation of innate (Toll-like receptor-4) and adaptive (IgA) immune systems and TJ proteins (occludin and claudin-3) were decreased after ethanol binges. Pretreatment with OEA reduced intestinal inflammation and immune activation and partially preserved the TJ structure affected by alcohol binges but had no effect on alcohol-induced apoptosis. Ultrastructural analyses of colonic TJs revealed dilated TJs in all ethanol groups, with less electron-dense material in non-pretreated rats. The protective effects of i.p. OEA did not reduce bacterial translocation to the MLN. However, intragastric OEA administration significantly reduced plasma LPS levels and bacterial translocation to the MLN. CONCLUSION AND IMPLICATIONS: OEA-based pharmacotherapies could potentially be useful to treat disorders characterized by intestinal barrier dysfunction, including alcohol abuse.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Endocannabinoids/pharmacology , Ethanol/administration & dosage , Ethanol/adverse effects , Intestinal Mucosa/drug effects , Oleic Acids/pharmacology , Alcoholism/physiopathology , Animals , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/prevention & control , Intestinal Mucosa/metabolism , Male , Rats , Rats, Wistar
3.
Neuroscience ; 286: 97-108, 2015 Feb 12.
Article in English | MEDLINE | ID: mdl-25463524

ABSTRACT

Methamphetamine exposure reduces hippocampal long-term potentiation (LTP) and neurogenesis and these alterations partially contribute to hippocampal maladaptive plasticity. The potential mechanisms underlying methamphetamine-induced maladaptive plasticity were identified in the present study. Expression of brain-derived neurotrophic factor (BDNF; a regulator of LTP and neurogenesis), and its receptor tropomyosin-related kinase B (TrkB) were studied in the dorsal and ventral hippocampal tissue lysates in rats that intravenously self-administered methamphetamine in a limited access (1h/day) or extended access (6h/day) paradigm for 17days post baseline sessions. Extended access methamphetamine enhanced expression of BDNF with significant effects observed in the dorsal and ventral hippocampus. Methamphetamine-induced enhancements in BDNF expression were not associated with TrkB receptor activation as indicated by phospho (p)-TrkB-706 levels. Conversely, methamphetamine produced hypophosphorylation of N-methyl-d-aspartate (NMDA) receptor subunit 2B (GluN2B) at Tyr-1472 in the ventral hippocampus, indicating reduced receptor activation. In addition, methamphetamine enhanced expression of anti-apoptotic protein Bcl-2 and reduced pro-apoptotic protein Bax levels in the ventral hippocampus, suggesting a mechanism for reducing cell death. Analysis of Akt, a pro-survival kinase that suppresses apoptotic pathways and pAkt at Ser-473 demonstrated that extended access methamphetamine reduces Akt expression in the ventral hippocampus. These data reveal that alterations in Bcl-2 and Bax levels by methamphetamine were not associated with enhanced Akt expression. Given that hippocampal function and neurogenesis vary in a subregion-specific fashion, where dorsal hippocampus regulates spatial processing and has higher levels of neurogenesis, whereas ventral hippocampus regulates anxiety-related behaviors, these data suggest that methamphetamine self-administration initiates distinct allostatic changes in hippocampal subregions that may contribute to the altered synaptic activity in the hippocampus, which may underlie enhanced negative affective symptoms and perpetuation of the addiction cycle.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Hippocampus/drug effects , Methamphetamine/administration & dosage , Receptor, trkB/metabolism , Animals , Apoptosis/drug effects , Cell Death/drug effects , Male , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/metabolism , Self Administration , bcl-2-Associated X Protein/metabolism
4.
Pharmacol Biochem Behav ; 98(2): 220-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21163296

ABSTRACT

Cannabinoid CB1 receptor and cholecystokinin-1 (CCK(1)) receptors are located in peripheral nerve terminals of the gut, where they mediate satiety signals. Here we describe a detailed analysis of the interaction of both receptors in the control of feeding of food-deprived rats. Male Wistar rats were deprived for food 24h before testing. Rats were pre-treated with SR141716A (Rimonabant) or WIN 55,212-2 before CCK-8 sulphated administration and tested for food intake 60, 120 and 240 min after last drug injection. In parallel, the effect of Lorglumide--a CCK(1) receptor antagonist--pre-treatment was evaluated on feeding behaviour after SR141716A administration. Results show that SR141716A activates c-Fos expression in brainstem areas receiving vagal inputs. Blockade of CB1 receptors with SR141716A (1 mg/kg) reduces feeding and display additive satiety induction with the CCK(1) receptor agonist CCK-8 sulphated (5, 10, 25 µg/kg). The effect of SR141716A is not blocked by Lorglumide (10 mg/kg), indicating independent sites of action. Conversely, the administration of the CB1 agonist WIN 55,212-2 (2 mg/kg) reduced satiety induced by CCK-8. In conclusion, these results report additive anorectic actions for CCK1 activation and peripheral CB1 receptor blockade providing a framework for combined therapies in the treatment of eating disorders.


Subject(s)
Feeding Behavior/drug effects , Feeding Behavior/physiology , Receptor, Cannabinoid, CB1/antagonists & inhibitors , Sincalide/administration & dosage , Animals , Anorexia/etiology , Anorexia/physiopathology , Benzoxazines/administration & dosage , Brain/drug effects , Brain/physiology , Drug Synergism , Gene Expression/drug effects , Genes, fos/drug effects , Male , Morpholines/administration & dosage , Naphthalenes/administration & dosage , Piperidines/administration & dosage , Proglumide/administration & dosage , Proglumide/analogs & derivatives , Pyrazoles/administration & dosage , Rats , Rats, Wistar , Receptor, Cannabinoid, CB1/agonists , Receptor, Cannabinoid, CB1/physiology , Receptor, Cholecystokinin B/antagonists & inhibitors , Rimonabant
5.
J Endocrinol Invest ; 32(6): 538-41, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19474528

ABSTRACT

BACKGROUND AND AIMS: Metabolic syndrome (MS) may be associated with the presence of an energy-sparing metabolism that predisposes to the excess accumulation of body fat. This study examined the relationship between reported energy intake and obesity in individuals with and without MS. METHODS AND RESULTS: Ninety consecutive non-diabetic obese subjects were divided into 2 groups based on the presence (MS+: no.=50) or absence (MS-: no.=40) of MS. The study design was cross-sectional. The 3-day food record method was used to assess the subjects' usual energy intake and the Diet Readiness Test (DRT) was also administered. Compared to the MS- group, the MS+ group had a significantly higher body weight, body mass index (mean+/-SEM: 39.1+/-1.3 vs 31.5+/-0.9, p<0.001) and fat mass. The absolute energy intake of the MS+ group (8629+/-331 kJ/24h) did not differ from that of the MS- group (8571+/-515 kJ/24h; p=ns). The daily energy intake normalized for the fat-free mass (FFM) size was higher in the MS- group (163+/-8 kJ/kg-FFM x 24h) than in the MS+ group (138+/-4 kJ/kg-FFM x 24h; p<0.03). The DRT test results were similar in both groups except that section 6 (exercise patterns and attitudes) score was lower in the MS+ group (10.0+/-0.5) than in the MS- group (11.9+/-0.5; p<0.01). CONCLUSION: The results of this study support the hypothesis that subjects with MS have an energy-sparing metabolism.


Subject(s)
Energy Intake/physiology , Metabolic Syndrome/metabolism , Adult , Basal Metabolism/physiology , Blood Glucose/metabolism , Blood Pressure/physiology , Body Composition , Body Mass Index , Body Weight/physiology , Female , Heart Rate/physiology , Humans , Insulin/blood , Linear Models , Male , Metabolic Syndrome/blood , Obesity/blood , Obesity/metabolism
6.
J Endocrinol Invest ; 30(3): 230-5, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17505157

ABSTRACT

Although subclinical hyperthyroidism (SCH) has been associated with increased risk of osteoporosis and cardiac arrhythmias, its treatment is still controversial. This study was designed as a prospective, randomized, intervention, control-study with a 1-year follow-up in order to investigate whether normalization of serum TSH in SCH using methimazole has favorable bone and heart clinical effects. Fourteen patients with endogenous SCH (not Graves' disease) were enrolled, 7 (5 women/2 men; group T) were treated with methimazole (2.5-7.5 mg/day), and 7 (5 women/2 men; group C) were followed without treatment; 10 healthy subjects were also included in the study as controls. Serum free-T3 (FT3), free-T4 (FT4) and TSH, thyroid echography, bone stiffness index (SI), as measured by heel ultrasonometry, and 24-h electrocardiography monitoring were obtained. SCH patients exhibited higher systolic and diastolic blood pressure than control subjects. They also had a significantly higher number of both ventricular premature beats (VPB) (mean+/-SEM: 681+/-238 vs 6+/-2 beats/24 h; p<0.02) and atrial premature beats (APB) (mean+/-SEM: 495+/-331 vs 7+/-2 beats/24 h; p<0.0001), and a lower SI (66+/-5 vs 96+/-3; p<0.001). Twelve months after normalization of TSH with the use of methimazole, the number of VPB decreased significantly (947+/-443 vs 214+/-109 beats/24 h; p<0.05) while it remained unchanged in untreated SCH patients (414+/-163 vs 487+/-152 beats/24 h; p=ns). An insignificant therapy effect was observed as far as APB were concerned (826+/-660 vs 144+/-75 beats/24 h; p=ns), however their number increased significantly in the untreated group (463+/-49 vs 215+/-46 beats/24 h; p<0.05). The SI increased significantly as a result of therapy in group T (64.1+/-4.8 vs 70.0+/-5.3; p<0.02) and was further reduced in group C at the end of the study (69.1+/-7.3 vs 62.9+/-7.1; p<0.001). No adverse effect was observed in group T. In conclusion, anti-thyroid therapy seems to have favor-able bone and heart clinical effects in subjects with endogenous SCH.


Subject(s)
Antithyroid Agents/therapeutic use , Blood Pressure/drug effects , Bone Density/drug effects , Heart Rate/drug effects , Hyperthyroidism/drug therapy , Antithyroid Agents/pharmacology , Blood Pressure/physiology , Bone Density/physiology , Female , Follow-Up Studies , Heart Rate/physiology , Humans , Hyperthyroidism/blood , Hyperthyroidism/physiopathology , Male , Middle Aged , Prospective Studies , Thyroid Hormones/blood
7.
Eur J Neurosci ; 25(5): 1517-28, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17425578

ABSTRACT

The dopaminergic system plays important roles in the modulation of olfactory transmission. The present study examines the distribution of dopaminergic cells and the content of dopamine (DA) and its metabolites in control and deprived olfactory bulbs (OB), focusing on the differences between sexes. The content of DA and of its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were measured by HPLC. The morphology and distribution of dopaminergic neurons were studied using tyrosine hydroxylase (TH) immunohistochemistry. Cells were typified with TH-parvalbumin, TH-cholecystokinin or TH-neurocalcin double-immunofluorescence assays. Biochemical analyses revealed sex differences in the content of DA and of its metabolites. In normal conditions, the OBs of male rats had higher concentrations of DA, DOPAC and HVA than the OBs of females. The immunohistochemical data pointed to sex differences in the number of TH-immunopositive cells (higher in male than in female rats). Colocalization analyses revealed that dopaminergic cells constitute a different cell subpopulation from those labelled after parvalbumin, cholecystokinin or neurocalcin immunostaining. Unilateral olfactory deprivation caused dramatic alterations in the dopaminergic system. The DA content and the density of dopaminergic cells decreased, the contents of DA and DOPAC as well as TH immunoreactivity were similar in deprived males and females and, finally, the metabolite/neurotransmitter ratio increased. Our results show that the dopaminergic modulation of olfactory transmission seems to differ between males and females and that it is regulated by peripheral olfactory activity. A possible role of the dopaminergic system in the sexually different olfactory sensitivity, discrimination and memory is discussed.


Subject(s)
Catechols/metabolism , Functional Laterality/physiology , Olfactory Bulb/metabolism , Sensory Deprivation/physiology , Sex Characteristics , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Animals, Newborn , Chromatography, High Pressure Liquid/methods , Dopamine/metabolism , Female , Homovanillic Acid/metabolism , Male , Nerve Tissue Proteins/metabolism , Pregnancy , Rats , Tyrosine 3-Monooxygenase/metabolism
8.
J Neurochem ; 100(4): 924-38, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17266734

ABSTRACT

The serotonergic system plays a key role in the modulation of olfactory processing. The present study examined the plastic response of this centrifugal system after unilateral naris occlusion, analysing both serotonergic afferents and receptors in the main olfactory bulb. After 60 days of sensory deprivation, the serotonergic system exhibited adaptive changes. Olfactory deprivation caused a general increase in the number of fibres immunopositive for serotonin but not of those immunopositive for the serotonin transporter. HPLC data revealed an increase in serotonin levels but not in those of its major metabolite, 5-hydroxyindole acetic acid, resulting in a decrease in the 5-hydroxyindole acetic acid/serotonin ratio. These changes were observed not only in the deprived but also in the contralateral olfactory bulb. Double serotonin-tyrosine hydroxylase immunolabelling revealed that the glomerular regions of the deprived olfactory bulb with a high serotonergic fibre density showed a strong reduction in tyrosine hydroxylase. Finally, the serotonin(2A) receptor distribution density and the number of juxtaglomerular cells immunopositive for serotonin(2A) receptor remained unaltered after olfactory deprivation. Environmental stimulation modulated the serotonergic afferents to the olfactory bulb. Our results indicate the presence of a bilateral accumulation of serotonin in the serotonergic axon network, with no changes in serotonin(2A) receptor density after unilateral olfactory deprivation.


Subject(s)
Functional Laterality/physiology , Olfactory Bulb/metabolism , Olfactory Pathways/metabolism , Sensory Deprivation , Serotonin/metabolism , Animals , Animals, Newborn , Autoradiography/methods , Chromatography, High Pressure Liquid/methods , Female , Fluorescent Antibody Technique/methods , Pregnancy , Rats , Rats, Wistar , Receptors, Serotonin/metabolism , Tyrosine 3-Monooxygenase/metabolism
9.
Neuroscience ; 141(4): 2117-28, 2006 Sep 15.
Article in English | MEDLINE | ID: mdl-16809000

ABSTRACT

The lack of environmental olfactory stimulation produced by sensory deprivation causes significant changes in the deprived olfactory bulb. Olfactory transmission in the main olfactory bulb (MOB) is strongly modulated by centrifugal systems. The present report examines the effects of unilateral deprivation on the noradrenergic and cholinergic centrifugal systems innervating the MOB. The morphology, distribution, and density of positive axons were studied in the MOBs of control and deprived rats, using dopamine-beta-hydroxylase (DBH)-immunohistochemistry and acetylcholinesterase (AChE) histochemistry in serial sections. Catecholamine content was compared among the different groups of MOBs (control, contralateral, and ipsilateral to the deprivation) using high-performance liquid chromatography analysis. Sensory deprivation revealed that the noradrenergic system developed adaptive plastic changes after olfactory deprivation, including important modifications in its fiber density and distribution, while no differences in cholinergic innervation were observed under the same conditions. The noradrenergic system underwent an important alteration in the glomerular layer, in which some glomeruli showed a dense noradrenergic innervation that was not detected in control animals. The DBH-positive glomeruli with the highest noradrenergic fiber density were compared with AChE-stained sections and it was observed that the strongly noradrenergic-innervated glomeruli were always atypical glomeruli (characterized by their strong degree of cholinergic innervation). In addition to the morphological findings, our biochemical data revealed that olfactory deprivation caused a decrease in the content of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid in the ipsilateral MOB in comparison to the contralateral and control MOBs, together with an increase in noradrenaline levels in both the ipsilateral and contralateral MOBs. Our results show that regulation of the noradrenergic centrifugal system in the MOB depends on environmental olfactory stimulation and that it is highly reactive to sensory deprivation. By contrast, the cholinergic system is fairly stable and does not exhibit clear changes after the loss of sensory inputs.


Subject(s)
Acetylcholine/metabolism , Functional Laterality/physiology , Nerve Fibers/metabolism , Norepinephrine/metabolism , Olfactory Bulb/physiology , Sensory Deprivation/physiology , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Animals, Newborn , Brain Chemistry/physiology , Chromatography, High Pressure Liquid/methods , Dopamine/metabolism , Dopamine beta-Hydroxylase/metabolism , Female , Immunohistochemistry/methods , Male , Olfactory Bulb/cytology , Pregnancy , Rats
10.
Neuroscience ; 135(4): 1095-105, 2005.
Article in English | MEDLINE | ID: mdl-16165281

ABSTRACT

3,4-Methylenedioxymethamphetamine (ecstasy) increases mature interleukin-1beta production in rat brain shortly after injection. This effect is a consequence of the 3,4-methylenedioxymethamphetamine-induced hyperthermia and is reduced when rats are maintained at low ambient room temperature. Since interleukin-1beta is generated as an inactive 31-kDa precursor protein and processed into mature form by caspase-1, we have now examined the effect of 3,4-methylenedioxymethamphetamine on pro-interleukin-1beta production and caspase-1-like protease activity in the hypothalamus and frontal cortex of Dark Agouti rats. 3,4-Methylenedioxymethamphetamine increased the immunoreactivity of pro-interleukin-1beta in frontal cortex, not in hypothalamus, 3 h and 6 h after administration. Caspase-1-like protease activity was increased in frontal cortex 3 h after 3,4-methylenedioxymethamphetamine injection compared with saline-treated animals. 3,4-Methylenedioxymethamphetamine did not modify the expression of pro-caspase-1 but increased the immunoreactivity for the caspase-1 active cleavage product (p20) in frontal cortex 3 h after dosing. No change on caspase-1-like protease activity was observed in hypothalamus. The basal immunoreactivity of pro-interleukin-1beta and caspase-1-like protease activity was higher in the hypothalamus than in frontal cortex of control (saline-treated) animals. These data indicate that 3,4-methylenedioxymethamphetamine alters, in a region-specific manner, the mechanisms which regulate interleukin-1beta production in the brain of Dark Agouti rats and suggest that the release of interleukin-1beta in hypothalamus may be regulated independently of caspase-1 activation. Administration (i.c.v.) of interleukin-1beta enhanced the 3,4-methylenedioxymethamphetamine-induced long-term loss of brain 5-HT parameters and immediate hyperthermia. Neither of these effects was observed when interleukin-1beta was given into hippocampus. These results indicate that exogenous interleukin-1beta potentiates 3,4-methylenedioxymethamphetamine neurotoxicity as a consequence of its effect on body temperature and suggest that the 3,4-methylenedioxymethamphetamine-induced rise in interleukin-1beta levels could in turn contribute to the maintenance of 3,4-methylenedioxymethamphetamine-induced hyperthermia and subsequent neurotoxicity.


Subject(s)
Frontal Lobe/drug effects , Hallucinogens/toxicity , Hypothalamus/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/toxicity , Peptide Hydrolases/drug effects , Protein Precursors/drug effects , Animals , Blotting, Western , Caspase 1/metabolism , Chromatography, High Pressure Liquid , Fever/chemically induced , Fever/physiopathology , Frontal Lobe/metabolism , Hydroxyindoleacetic Acid/metabolism , Hypothalamus/metabolism , Injections, Intraventricular , Interleukin-1/administration & dosage , Interleukin-1/metabolism , Neurons/drug effects , Neurons/pathology , Peptide Hydrolases/metabolism , Protein Precursors/metabolism , Rats , Serotonin/metabolism
11.
An Otorrinolaringol Ibero Am ; 25(4): 339-45, 1998.
Article in Spanish | MEDLINE | ID: mdl-9707755

ABSTRACT

Report of a carcinoma of renal clear cells, or hypernephroma, metastasized to parotid gland, in a 63 years old man. The occurrence of a mass progressively growing in link parotid was the early manifestation of the illness and the postsurgical anatomopathological study discovered the primary growth sitting in the kidney. Bibliographical survey of the subject and clinical, diagnostical and therapeutic features of this case as well.


Subject(s)
Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Parotid Neoplasms/secondary , Carcinoma, Renal Cell/diagnostic imaging , Humans , Kidney Neoplasms/diagnostic imaging , Male , Middle Aged , Parotid Neoplasms/diagnostic imaging , Tomography, X-Ray Computed
12.
Ann Ital Med Int ; 12(1): 11-4, 1997.
Article in Italian | MEDLINE | ID: mdl-9409946

ABSTRACT

Rickettsia conorii is the etiologic agent of Boutonneuse fever, a rickettsiosis of the spotted fever group that is endemic in Southern Italy. Chloramphenicol or tetracyclines are still the treatment of choice for this disease, and recently quinolones have also been utilized with success. In 1994-95, 39 otherwise healthy patients were admitted to our unit for Boutonneuse fever. They were treated, in random order, with quinolones (10 subjects received ciprofloxacin, 500 mg/12 h per os; 8 subjects received intravenous pefloxacin, 200 mg/12 h), or tetracyclines (21 subjects received intravenous rolitetracycline, 275 mg/12 h). Outcome was favorable in all cases and no significant complications were observed. However, in a significant number of cases, increased blood concentrations of glutamic-oxalacetic (68.4%) and glutamic-pyruvic (60.5%) transaminases were found. Above normal blood creatinine values were observed in 29.7% of the cases, and urinanalysis disclosed blood in 35.9% and proteins in 56.4% of the cases. Both tetracyclines and quinolones were well tolerated and effective, with apyrexia achieved after 2.7 +/- 0.1 days (mean +/- SEM). All patients were discharged after an average of 7.1 +/- 0.4 days. Liver and kidney function derangements seem to occur to some extent in the acute phase of Boutonneuse fever. This finding might partially explain the increased mortality rate reported for subjects with simultaneous systemic or organ diseases or when the administration of an effective antibiotic is delayed. Together with chloramphenicol and tetracyclines, quinolones might be considered as first line antibiotics.


Subject(s)
Boutonneuse Fever/drug therapy , Quinolones/therapeutic use , Tetracyclines/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Boutonneuse Fever/diagnosis , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...